Medicare Enrolled
Dr. Vikram Penumalli, MD
Diagnostic Neuroimaging (Psychiatry & Neurology) Physician · Greensboro, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Penumalli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Penumalli?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Penumalli
Dr. Vikram Penumalli is a diagnostic neuroimaging physician in Greensboro, NC, with 17 years of NPI registration. Based on federal Medicare data, Dr. Penumalli performed 314 Medicare services across 306 unique beneficiaries.
Between the years covered by Open Payments, Dr. Penumalli received a total of $9,892 from 88 pharmaceutical and/or device companies across 556 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in diagnostic neuroimaging (psychiatry & neurology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Penumalli is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ 314 Medicare services
$9,892 industry payments
Medicare Practice Summary
Medicare Utilization ↗314
Medicare services
306
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~18 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
88 | $118 | $395 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
69 | $78 | $260 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
53 | $78 | $400 |
| New patient office visit, complex (60-74 min) | 27 | $129 | $495 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $59 | $175 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
19 | $54 | $275 |
| MRI of upper spine without contrast An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine. |
18 | $51 | $275 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $113 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,892
Total received (2018-2024)
Avg $1,413/year across 7 years
Top 33% in NC for diagnostic neuroimaging (psychiatry & neurology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
556
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,350 (94.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$543 (5.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,729
2023
$2,037
2022
$1,107
2021
$463
2020
$231
2019
$1,844
2018
$1,481
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$500
ABBVIE INC.
$275
Biogen, Inc.
$225
UCB, Inc.
$215
Novartis Pharmaceuticals Corporation
$190
Celgene Corporation
$122
PFIZER INC.
$98
Lundbeck LLC
$90
CSL Behring
$85
ARGENX US, INC.
$82
Genentech USA, Inc.
$64
Takeda Pharmaceuticals U.S.A., Inc.
$58
Mallinckrodt Hospital Products Inc.
$55
Neurelis, Inc.
$52
BANNER LIFE SCIENCES, LLC
$51
TG Therapeutics, Inc.
$48
AstraZeneca Pharmaceuticals LP
$46
JAZZ PHARMACEUTICALS INC.
$45
Otsuka America Pharmaceutical, Inc.
$41
Teva Pharmaceuticals USA, Inc.
$40
Eisai Inc.
$37
Acorda Therapeutics, Inc
$35
Boston Scientific Corporation
$32
ACADIA Pharmaceuticals Inc
$28
HARMONY BIOSCIENCES LLC
$27
Novo Nordisk Inc
$27
Amgen Inc.
$24
Amneal Pharmaceuticals LLC
$21
EMD Serono, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$19
Axsome Therapeutics, Inc.
$18
Merz Pharmaceuticals, LLC
$16
Lilly USA, LLC
$16
Avadel CNS Pharmaceuticals, LLC
$14
SK Life Science, Inc.
$13
Top 3 companies account for 36.6% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$857
UCB, Inc.
$701
Alexion Pharmaceuticals, Inc.
$701
Novartis Pharmaceuticals Corporation
$692
ABBVIE INC.
$654
Amgen Inc.
$462
GENZYME CORPORATION
$326
CSL Behring
$307
Lundbeck LLC
$277
EMD Serono, Inc.
$273
Teva Pharmaceuticals USA, Inc.
$230
ACADIA Pharmaceuticals Inc
$206
Adamas Pharmaceuticals, Inc.
$180
Allergan Inc.
$179
Celgene Corporation
$169
JAZZ PHARMACEUTICALS INC.
$157
ARGENX US, INC.
$156
Merz Pharmaceuticals, LLC
$152
PFIZER INC.
$139
Neurocrine Biosciences, Inc.
$132
Acorda Therapeutics, Inc
$127
SK Life Science, Inc.
$123
Jazz Pharmaceuticals Inc.
$111
Mallinckrodt Hospital Products Inc.
$111
Neurelis, Inc.
$103
Genentech USA, Inc.
$100
Mitsubishi Tanabe Pharma America, Inc.
$94
Amneal Pharmaceuticals LLC
$93
Greenwich Biosciences, Inc.
$92
Medtronic, Inc.
$86
Eisai Inc.
$86
Avanir Pharmaceuticals, Inc.
$79
Otsuka America Pharmaceutical, Inc.
$75
GE HEALTHCARE
$75
Lilly USA, LLC
$71
Merz North America, Inc.
$69
Axsome Therapeutics, Inc.
$64
Takeda Pharmaceuticals U.S.A., Inc.
$58
Allergan, Inc.
$52
BANNER LIFE SCIENCES, LLC
$51
Bausch Health US, LLC
$49
Avion Pharmaceuticals
$49
Kyowa Kirin, Inc.
$48
TG Therapeutics, Inc.
$48
AstraZeneca Pharmaceuticals LP
$46
ARBOR PHARMACEUTICALS, INC.
$44
GRT US Holding, Inc.
$44
IMPEL PHARMACEUTICALS INC.
$43
Mallinckrodt LLC
$42
Vanda Pharmaceuticals Inc.
$39
Collegium Pharmaceutical, Inc.
$37
Mallinckrodt Enterprises LLC
$36
Grifols USA, LLC
$33
Boston Scientific Corporation
$32
HARMONY BIOSCIENCES LLC
$27
Novo Nordisk Inc
$27
Ipsen Biopharmaceuticals, Inc
$27
Sumitomo Pharma America, Inc.
$27
GE Healthcare
$26
Horizon Therapeutics plc
$25
US WorldMeds, LLC
$25
TG THERAPEUTICS, INC.
$24
Strongbridge US INC.
$23
Abbott Laboratories
$22
Microtransponder, Inc.
$21
Philips Electronics North America Corporation
$21
SCILEX PHARMACEUTICALS INC.
$19
Biohaven Pharmaceutical Holding Company Ltd.
$19
Regeneron Healthcare Solutions, Inc.
$18
SANOFI-AVENTIS U.S. LLC
$18
Banner Life Sciences, LLC
$17
Corium, LLC
$17
UPSHER-SMITH LABORATORIES LLC
$17
Sandoz Inc.
$17
Aprecia Pharmaceuticals, LLC
$16
Exeltis, USA Inc.
$16
Harmony Biosciences LLC
$15
AbbVie Inc.
$15
Supernus Pharmaceuticals, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$14
MERZ NORTH AMERICA, INC.
$14
Avadel CNS Pharmaceuticals, LLC
$14
Vertical Pharmaceuticals, LLC
$14
Alnylam Pharmaceuticals Inc.
$13
Assertio Therapeutics, Inc.
$13
Janssen Pharmaceuticals, Inc
$13
Impax Laboratories, Inc.
$12
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 22.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CAMBIA · COPAXONE · DUOPA · DYSPORT · Deep Brain Stimulation · Dhivy · Dysport · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · GILENYA · GOCOVRI · Gamunex-C · HETLIOZ · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · KEVEYIS · LEMTRADA · LEQEMBI · LEQVIO · LUMRYZ · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · Ocrevus · Ongentys · PANZYGA · POMPE - DISEASE · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PURIFIED CORTROPHIN GEL · QULIPTA · Qutenza · RADICAVA · RELEXXII · REXULTI · RYTARY · Radicava · Rebif · Repatha · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SUNOSI · Skyclarys · Spritam · Sunosi · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · Wakix · Wegovy · XEOMIN · XLSD · XYREM · XYWAV · Xadago · Xeomin · Xyrem · ZEPOSIA · ZTLido · Zilbrysq · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Diagnostic neuroimaging physicians within 10 mi
2
Per 100K population
0.4
County median income
$66,027
Nearest hospital
MOSES H. CONE MEMORIAL HOSPITAL, THE
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Penumalli is a clinical cardiology specialist, with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Penumalli experienced with new patient office visit (45-59 min)?
Based on Medicare claims data, Dr. Penumalli performed 88 new patient office visit (45-59 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Penumalli receive payments from pharmaceutical companies?
Yes. Dr. Penumalli received a total of $9,892 from 88 companies across 556 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Penumalli's costs compare to other diagnostic neuroimaging physicians in Greensboro?
Dr. Penumalli's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Penumalli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Diagnostic Neuroimaging Physicians in Greensboro
Browse diagnostic neuroimaging physicians in Greensboro ranked by procedure volume and transparency data.
Highest volume
Top Diagnostic Neuroimaging Physicians in NC
Diagnostic neuroimaging physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Diagnostic Neuroimaging Physicians in NC
Which NC diagnostic neuroimaging physicians receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology